BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 14, 2021
View Archived Issues
Gunagratinib safe and active in patients with advanced solid tumors
Read More
Stuart initiates patient enrollment in phase II study of ST-100 for dry eye disease
Read More
PRV-111 nanoengineered cisplatin patch shows promising safety and efficacy in patient with OSCC
Read More
Shanghai Ennova Biopharmaceutical patents new TRK inhibitors
Read More
Sunshine Lake Pharma presents new antimigraine drugs
Read More
Shijiazhuang Yiling Pharmaceutical identifies HIPK2 inhibitors
Read More
Albiero Pharma synthesizes new ASBT and/or NTCP inhibitors
Read More
Preliminary first-in-human data presented for BDC-1001 in HER2-expressing solid tumors
Read More
Ossianix patents TfR1-targeting antibodies for neurodegeneration
Read More
U.K.'s MHRA clears initiation of phase II trial of COVID-DROPS
Read More
Phase Ia/b data for APTO-253 in patients with relapsed/refractory AML or high-risk MDS
Read More
Preliminary phase I results for NEXI-002 in R/R MM reported at EHA
Read More
Novavax reports COVID-19 vaccine data against SARS-CoV-2 Beta variant
Read More
Preliminary assessment of [68Ga]NOTA-GUL for the diagnosis of prostate cancer
Read More
ImmVira completes first dosing in phase II trials of oncolytic virus product MVR-T3011
Read More
Dosing begins in phase I study of novel cystic fibrosis therapy ETD-001
Read More
Rohto initiates phase I/II study of UDI-001 in pediatric patients with cerebral palsy
Read More
New target identified for acetaminophen liver injury
Read More
Inceptor Bio uses seed funding to advance next-generation cell therapy platforms for cancer
Read More
Lilly opens phase II trial of LY-3437943 in type 2 diabetes
Read More
First-in-human study of Carna's CDC7 inhibitor AS-0141 begins dosing
Read More
FDA lifts partial clinical hold on phase II studies of ALX-148 in HNSCC
Read More